News Novo's Saxenda label to include cardio data Label will reflect heart benefit seen in LEADER trial.
News Biotech vTv believes small molecule GLP-1 pill can take on b... Pill could be effective in diabetes, with fewer GI effects.
News Oral insulin could still be a reality, says Novo Nordisk Last October Novo Nordisk announced that it had shelved plans to bring the world’s first oral insulin to market .
News Novo hopes data will boost new insulin in US and Germany Novo Nordisk hopes that new data supporting the cardiovascular and glycaemic safety of its Tresiba long-acting insulin will prove a game-changer in the US.
Views & Analysis ADA preview: cardio data in diabetes, drug costs and healthc... Invokana data could suggest cardio benefit for SGLT2 class.
News Third Rock in $2bn drug-hunting pact with China's Funnel New Chinese biotech Funnel has signed a $2bn-plus partnership with Third Rock Ventures, focused on using its AI platform to discover novel biologics.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.
